Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis

Hematology

Volumn 17, Issue SUPPL. 1, 2012, Pages

  Lazzari, M A ^a   Sanchez Luceros, A ^a   Woods, A I ^a   Alberto, M F ^a   Meschengieser, S S ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Bleeding phenotype; Physiological variations; Risk marker; Thrombosis; VWF

Indexed keywords

ENOXAPARIN; HIRUDIN; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; CORONARY ARTERY DISEASE; DISEASE SEVERITY; HEART INFARCTION; HUMAN; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; THROMBOSIS; UNSTABLE ANGINA PECTORIS; VON WILLEBRAND DISEASE;

HEMORRHAGE; HUMANS; RISK FACTORS; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 84859779755     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453312X13336169156618     Document Type: Article

References (10)

1. Sadler EJ. von Willebrand factor: two sides of a coin. J Thromb Haemost. 2005;3:1702-9.
2. Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, et al. ABO blood types: influence on infarct size, procedural characteristics and prognosis. Thromb Res. 2008;123:200-5.
3. Sanchez-Luceros A, Meschengieser SS, Marchese C, Votta R, Casais P, Woods AI, et al. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coagul Fibrinolysis. 2003;14:647-51.
4. Sanchez-Luceros A, Farias CE, Amaral MM, Kempfer AC, Votta R, Marchese C, et al. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thromb Haemost. 2004;92:1320-6.
5. Woods AI, Blanco AN, Chuit R, Meschengieser SS, Kempfer AC, Farías CE, et al. Major haemorrhage related to surgery in patients with type1 and possible type1 von Willebrand disease. Thromb Haemost. 2008;100:797-802.
6. Vischer UM. von Willebrand factor, endothelial dysfunction and cardiovascular disease. J Thromb Haemost. 2006;4:1186-93.
7. Campos M, Sun W, Yu F, Barbalic M, Tang W, Chambless LE, et al. Genetic determinants of plasma von Willebrand factor antigen level: a target gene SNP and haplotype analysis of ARIC cohort. Blood. 2011;117:5224-30.
8. Roldán V, Marín F, Muiña B, Torregrosa JM, Hernández-Romero D, Valdés M, et al. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol. 2011;57:2496-504.
9. Bongers TN, de Maat MPM, van Goor MLPJ, Bhagwanbali V, van Vliet HHDM, Gomez Garcia EB, et al. High von Willebrand factors levels increase the risk of first ischemic stroke. Stroke. 2006;37:2672-7.
10. Montalescot G, Collet JP, Lison L. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol. 2000;36:110-4.